Growth Metrics

Quest Diagnostics (DGX) Return on Equity (2017 - 2025)

Quest Diagnostics' Return on Equity history spans 17 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Equity rose 1.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, up 1.0%, while the annual FY2025 figure was 0.14%, 1.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.14% at Quest Diagnostics, up from 0.14% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.31% in Q4 2021 and bottomed at 0.07% in Q1 2021.
  • The 5-year median for Return on Equity is 0.14% (2023), against an average of 0.17%.
  • The largest YoY upside for Return on Equity was 22bps in 2022 against a maximum downside of -15bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.31% in 2021, then tumbled by -49bps to 0.16% in 2022, then dropped by -13bps to 0.14% in 2023, then decreased by -4bps to 0.13% in 2024, then increased by 5bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for DGX's Return on Equity are 0.14% (Q4 2025), 0.14% (Q3 2025), and 0.14% (Q2 2025).